DNTH Dianthus Therapeutics

Watchlist

Close Mar 10 16:00 ET

Pre 04:25 ET

720.39MMarket Cap-10.65P/E (TTM)

Dianthus Therapeutics Stock Analyst Ratings & Price Target

Updated: Feb 28, 2025

Based on 3 analysts giving stock ratings to Dianthus Therapeutics in the past 3 months

Strong Buy

Updated: Feb 28, 2025

The average Dianthus Therapeutics stock price target is 48.50 with a max estimate of 52.00 and a min estimate of 45.00

Review Dianthus Therapeutics earnings estimates

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer